half yearly, gsk fim and strategic alliances, page-9

hmmm the in vivo tests have got me in a little head spin. It says that in vivo tests were to be conducted early 2011. The prospectus did not even mention GSK. Could they have proceded with in vivo testings without informing the market? As the first GSK announcement informed the market that OBJ and GSK were in discussion regarding the next phase (technical evaluation, in vivo testing). It is of my belief that the market cannot be trading in an un-informed manner. If the in vivo tests were to have been proceeded with surely the market would have been informed in an announcement by GSK. So by that angle i don't think that the in vivo tests have begun yet. Whats your opinion on this surges?